Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
Exenatide once-weekly (Bydureon)

Original article by: Alexandra Denby

Source: London New Drugs Group

Keywords: exenatide, Bydureon, diabetes type 2,

Date published: 19/05/2011 15:03

Summary
by: Alexandra Denby
  · The EU marketing authorisation for a once-weekly exenatide injection (Bydureon®) for the treatment of type 2 diabetes was approved in April 2011.

· This review appraises the trial data supporting the use of exenatide once-weekly.

 

About this library entry
Category: 6.1.2 Antidiabetic drugs | Diabetes | Drug reviews
NeLM area:  Evidence > Drug Specific Reviews
Exenatide_onceweekly_May2011.pdf

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Back